Paragon Wealth Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-355
Closed -$39.4K 159
2022
Q4
$39.4K Sell
355
-433
-55% -$44.3K 0.05% 73
2022
Q3
$68K Buy
+788
New +$70.3K 0.07% 35

Other funds holding MRK

Paragon Wealth Strategies's MRK Position: Q1 2023 in Review

Paragon Wealth Strategies sold out of Merck (MRK) in Q1 2023, closing a stake of 355 shares — an estimated $39.4K sold.

Paragon Wealth Strategies first reported a position in MRK in Q3 2022 and held it in 2 quarters. The position peaked at $68K in Q3 2022. 3,180 funds tracked by Wall St. Rank hold MRK as of Q1 2023.

  • Paragon Wealth Strategies reported no remaining Merck position as of Q1 2023 after selling out during the quarter.
  • Paragon Wealth Strategies sold 355 Merck shares in Q1 2023, an estimated $39.4K.
  • Paragon Wealth Strategies first reported a position in Merck in Q3 2022 and held it in 2 quarters.
  • Paragon Wealth Strategies's Merck position peaked at $68K in Q3 2022.
  • 3,180 funds tracked by Wall St. Rank held Merck as of Q1 2023.

Based on Paragon Wealth Strategies's 13F filing for Q1 2023, filed 26 Apr 2023.